News
Performance
Price return has been average, nothing exciting
Valuation
Seems to be overvalued vs the market average
Growth
Financials growth has been moderate for a few years
Profitability
Showing good signs of profitability & efficiency
Entry point
The stock is overpriced and in the overbought zone
Red flags
The stock has a moderate number of red flags
Go Pro! to unlock score, rank
and other metrics
How to use scorecard? Learn more
Sudarshan Pharma Industries Ltd. to Acquire 100% Stake in Ratna Lifesciences Pvt. Ltd. for ₹5.5 Crore
1 year ago•The Hindu Businessline